ECBF joins Novo Seeds and Sofinnova Partners in EUR11.5m round in Biosyntia

The European Circular Bioeconomy Fund (ECBF) expands its industrial biotechnology portfolio by joining the financing Series B of danish Biosyntia ApS. Biosyntia is a precision fermentation company focused on bio-based production for products such as vitamins and other ingredients.

Read more

Lonza invests CHF500m in Large-Scale Facility in Stein (CH)

Large CDMO Lonza to build a new large-scale, commercial drug product facility including fill and finish to support customers across the entire product life cycle in Switzerland, investment of CHF500m.

Read more

Urovant Sciences cashes in $75m in licence deal from Pierre Fabre

French drugmaker Pierre Fabre Médicaments will pay $75m for an exclusive licence to to commercialise Urovant Sciences’ drug vibegron for the treatment of overactive bladder in Europe.

Read more

CureVac NV sues BioNTech for IP infringement

German mRNA vaccine developer CureVac, whose COVID-19 vaccine was not effective, on Monday sued BioNTech/Pfizer for infringement of four patents.

Read more

French Ipsen falls after Epizyme take-over announcement

Shares of French drugmaker Ipsen fell by 4.4% at Euronext Paris after the company announced to take over US cancer specialist Epizyme Inc. for $247m.

Read more

TWB announces winners in industrial biotech start-up contest

At the end of the TWB Start-up day, which was attended by more than 200 biotech professionals, two industrial biotechnology companies were awarded prizes worth €50,000.

Read more